The Phase I monotherapy trial and the Phase Ib combination therapy trial demonstrated an excellent safety profile and initial indications of clinical benefit were observed. BSI-201 demonstrated an
The acquisition brings to Kendle extensive world-class scientific expertise with psychopharmacology high-end exploratory or translational medicine capabilities, from first-in-human to proof-of-concept trial conduct, as well as drug development
The Phase I study demonstrated that intravenously administered radiolabeled TM601 is able to cross the blood-brain barrier, specifically bind to tumor tissue, and is actively internalized by tumor
The interim results demonstrate that the treatment has been well tolerated to date, with eight of 16 evaluable patients experiencing stable disease for periods ranging from two to
In the study, the two-year survival rate for patients treated with Vidaza was almost doubled with 50.8% compared to 26.2% for conventional care regimens (CCR). This improved survival
The Committee for Medicinal Products for Human Use (CHMP) positive opinion is based on a comprehensive clinical trial program including the results from the Signal and Aurora clinical
Merck also said that a New Jersey appellate division has overturned the punitive damage and consumer fraud awards in the 2006 verdict in a two-plaintiff Vioxx trial involving
C5 Medical’s ZirDent CAD/CAM Blocks are available in an unlimited variety of shapes, sizes and sintering options – pre-sintered, fully sintered and HIP’d – to meet each customer’s
The new funding will be used to further develop its cancer and viral disease product platform, including IRX-2 (citoplurikin), the company’s lead candidate for cancer treatment. The company
The community based diabetes prevention program will determine optimal ways to translate the programs developed for research studies of lifestyle interventions for diabetes prevention to real-life settings in
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.